AVITA Medical study shows PermeaDerm costs 70% less than allograft

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. NVDA
2. PSKY
3. META
4. LGND
5. SPY
6. MONC:IM
7. PTON
8. NYXH
9. LXEO
10. MONRY

Go back to AVITA Medical study shows PermeaDerm costs 70% less than allograft
(NASDAQ: RCEL) Delayed: 11.48 +0.64 (5.90%)
Previous Close $10.84    52 Week High $ 
Open $10.86    52 Week Low $ 
Day High $11.60    P/E N/A 
Day Low $10.71    EPS $ 
Volume 59,811